Floatz logo

Eloxatin

Liver Transplant

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Liver Transplant cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
Novartis Pharmaceuticals
Phase 4B
Bms-907351
University Health Network, Toronto
Phase 2CCC
LENVATINIB
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1/2CCC
FLUOROURACILUM
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1/2CC
Rivoceranib
Zhejiang University
Phase 1/2CC
Calcium folinate pentahydrate
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1/2CC
AMINO ACIDS, BRANCHED-CHAIN
University of Arkansas
N/AD

Same molecule, other indications

Eloxatin is also rated in:

exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
colon adenocarcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →